July 18th 11:00 – 12:30 PM EST; 4:00 PM – 5:30 PM BST
Moderator:
Jeff Guild, VP Business Development and Professional Services, BlueTech® Research
Panelists:
Kim Soerensen, CTO, WABAG
Joshua P. Boltz Ph. D, P. E, BCEE, F. IWA, Senior Technologist, CH2M Hill
Laura Marcolini, President, Biowater US
Afnan Din, Vice President, Headworks BIO
In the past fifteen years, Moving Bed Biofilm Reactors (MBBR) and Integrated Fixed film Activated Sludge (IFAS) evolved from a nascent technology fighting for a market niche against conventional activated sludge and high rate membrane bioreactors into a technology in the process of “going mainstream” in both new builds and retrofits in industrial and municipal wastewater settings.
However, following the pattern of previous technologies hitting mainstream, “me too” offerings are beginning to appear as both new and established players recognize the need to further innovate. Novel media for high rate operation, enhanced nutrient removal and even anaerobic systems are just a selection of the types of innovation currently undergoing commercialization in this area.
This webinar will provide an overview on the current market state of MBBR and IFAS systems and highlight several innovative fixed film systems currently being developed.
Questions to be answered:
- How will MBBR/IFAS technology providers differentiate themselves as the market becomes increasingly commoditized?
- What are the technological limitations of current commercially available IFAS/MBBR systems?
- What technological innovations are happening in this sector?
- How do these innovative technologies compare with established MBBR/IFAS systems?
- In what market areas are new entrants in this market positioning themselves?
- What is the current installed capacity of MBBR and IFAS worldwide?
- In what markets are MBBR and IFAS established?
- What regions or industries are seeing a strong uptake in MBBR/ IFAS systems?
- Where do leading technology providers see the greatest potential for innovation in this sector?
What you will learn?
- The current applications, markets and limitations of conventional MBBR and IFAS systems.
- An understanding of how technology providers in this market area compete.
- The current size of the MBBR/IFAS market.
- Where the latest technological breakthroughs are happening in this area.
- Where emerging new build and retrofit markets are developing.
Who should attend?
- Investors looking to understand the market opportunity in advanced biological treatment systems.
- Technology providers looking for technology gap and unmet needs.
- Utilities who wish to understand the economic & technical issues and future directions.
For more information and to register, please visit http://bit.ly/BlueTech_July_Webinar_Moving_Beyond_MBBR_and_IFAS.
